SlideShare a Scribd company logo

61 it015707-mar-performance card

•
•
Rameshwar Srivastava
Rameshwar Srivastava

This document summarizes the sales performance of Rameshvar Lal Srivastava for March 2017. Key details include: - Secondary sales achievement was 88.5% of target for the month and 69.38 for the year-to-date. - Brand achievement for core brands was 97.3% for the month and 25.03% for the year-to-date. - Incremental sales per meeting was Rs. 7.5 for the month and Rs. 1.81 for the year-to-date. - Rameshvar Lal Srivastava's ranking within his division and zone was 0 for both the month and year-to-date.

Related slideshows

Daily equity-report by epic research 29-02-2012
Daily equity-report by epic research 29-02-2012Daily equity-report by epic research 29-02-2012
Daily equity-report by epic research 29-02-2012
 
DAILY EQUTY REPORT BY EPIC RESEARCH-08 MAY 2012
DAILY EQUTY REPORT BY EPIC RESEARCH-08 MAY 2012DAILY EQUTY REPORT BY EPIC RESEARCH-08 MAY 2012
DAILY EQUTY REPORT BY EPIC RESEARCH-08 MAY 2012
 
DAILY EQUTY REPORT BY EPIC RESEARCH-18 APRIL 2012
DAILY EQUTY REPORT BY EPIC RESEARCH-18 APRIL 2012DAILY EQUTY REPORT BY EPIC RESEARCH-18 APRIL 2012
DAILY EQUTY REPORT BY EPIC RESEARCH-18 APRIL 2012
 
1 of 2
Download to read offline
SALES SCORECARD March 2017 Name Designation Date of Joining Territory Zone Division Rameshvar Lal Srivastava - 731651 TBM 05-JAN-2017 LUCKNOW - IT015707 NORTH3 ACUTE CARE HPL Rank - Division HPL Rank - Zone 0 0 Sales Performance Details - Value Current Month Year - To - Date Brand Class Target Sales Ach % Claims LY Sales Growth PMPM Closing Target Sales Ach % Claims LY Sales Growth PMPM BETONIN AST Build 1.95 0.98 50.4 0.0 0.77 28 0.98 0.8 5.8 3.97 68.4 0.0 1.64 142 1.32 LOBATE GM NEO Build 1.22 2.6 212.2 0.0 0.72 261 2.6 0.74 3.73 6.98 186.9 0.0 1.5 365 2.33 Zimnic Group Build 0.05 0.04 79.0 0.01 0.03 49 0.04 0.15 0.15 0.12 80.6 0.02 0.23 -46 0.04 Deletus Group Invest 0.34 0.12 34.7 0.0 0.03 313 0.12 0.29 1.23 0.52 42.5 0.0 0.19 182 0.17 SURBEX -XT Invest 0.33 0.04 12.4 0.0 0.29 -86 0.04 0.46 1.04 0.36 34.8 0.0 0.48 -25 0.12 AQUAVIRON INJECTION 1ML Maintain 0.17 0.1 60.6 0.0 0.21 -50 0.1 0.18 0.55 0.55 100.3 0.0 0.56 -1 0.18 AVOMINE TABS Maintain 0.12 0.06 53.2 0.0 0.08 -19 0.06 0.23 0.37 0.16 44.0 0.0 0.27 -38 0.05 HAEMACCEL 500ML Maintain 3.64 2.15 58.9 0.01 4.08 -47 2.15 2.15 7.24 5.29 73.0 0.02 5.32 -1 1.76 LYSUPRA Maintain 0.04 0.03 81.3 0.0 0.08 -57 0.03 0.09 0.1 0.06 56.7 0.0 0.14 -59 0.02 Paraxin Group Maintain 0.68 1.01 148.2 0.07 0.76 33 1.01 1.01 2.07 1.62 78.3 0.07 2.06 -21 0.54 BI Total 3.9 3.8 97.3 0.01 1.84 107 3.8 2.47 12.0 12.01 100.1 0.03 4.08 194 4.0 Exit Total 0.0 0.0 0.0 0.0 0.01 -95 0.0 0.03 0.0 0.0 0.0 0.0 0.06 -106 0.0 Milk Total 0.53 1.07 203.0 0.03 0.26 308 1.07 0.54 1.69 2.71 160.5 0.04 1.02 167 0.9 Grand Total 9.63 8.53 88.5 0.12 7.5 14 8.53 7.78 26.4 25.08 95.0 0.17 14.91 68 8.36 Sales Performance Details - Volume Current Month Year - To - Date SKU Class Target Sales Ach % Claims LY Sales Growth PMPM Closing Target Sales Ach % Claims LY Sales Growth PMPM BETONIN AST 170 ML (Without Folic Build 2311 535 23 0 704 -24 535 737 6858 3310 48 2 1351 145 1103 BETONIN AST 400 ML (Without Folic Build 574 666 116 0 415 60 666 360 1711 1992 116 0 979 103 664 LOBATE GM NEO 15GM Build 2918 6967 238 2 2118 229 6967 1996 8902 18725 210 5 4423 323 6241 DELETUS D 100ML SYRUP Invest 322 135 41 0 0 0 135 131 1172 601 51 0 0 0 200 NEW DELETUS BX SYRUP MANGO Invest 52 20 38 0 24 -17 20 138 200 53 26 6 159 -67 17 SURBEX -XT 15S Invest 557 63 11 0 511 -88 63 763 1771 647 36 2 868 -25 215 AQUAVIRON INJ. 1 ML Maintain 229 137 59 3 302 -55 137 237 738 730 98 4 815 -10 243 HAEMACCEL 500ML Maintain 1773 1189 67 4 2170 -45 1189 1208 3541 2955 83 9 2830 4 985 PARAXIN CAPSULES 250 MG 10S Maintain 535 2380 444 0 1598 49 2380 1196 1608 3500 217 3 3733 -6 1166 PARAXIN CAPSULES 500MG 10 S Maintain 379 87 23 0 54 61 87 166 1100 154 14 0 449 -66 51 Brand Targets - Cycle 1 2017 Value Brand Class Jan '17 Feb '17 Mar '17 Apr '17 BETONIN AST Build 1.9 1.95 1.95 2.49 LOBATE GM NEO Build 1.27 1.24 1.22 1.59 Zimnic Group Build 0.05 0.05 0.05 0.06 Deletus Group Invest 0.47 0.43 0.34 0.35 SURBEX -XT Invest 0.36 0.36 0.33 0.39 BI Total 4.06 4.04 3.9 4.89 Grand Total 8.31 8.46 9.63 12.65 Volume SKU Jan '17 Feb '17 Mar '17 Apr '17 AQUAVIRON INJ. 1 ML 280 229 229 229 BETONIN AST 170 ML (Without Folic Acid) 2241 2306 2311 2932 BETONIN AST 400 ML (Without Folic Acid) 560 577 574 742 DELETUS D 100ML SYRUP 441 409 322 333 HAEMACCEL 500ML 788 980 1773 2412 LOBATE GM NEO 15GM 3029 2955 2918 3770 NEW DELETUS BX SYRUP MANGO 100ML 79 69 52 54 PARAXIN CAPSULES 250 MG 10S 554 519 535 760 PARAXIN CAPSULES 500MG 10 S 353 368 379 558 SURBEX -XT 15S 607 607 557 657
HPL SCORECARD March 2017 Name Designation Date of Joining Territory Zone Division Rameshvar Lal Srivastava - 731651 TBM 05-JAN-2017 LUCKNOW - IT015707 NORTH3 ACUTE CARE HPL Rank - Division HPL Rank - Zone 0 0 YTD Performance Details Cycle 1 Cycle 2 Cycle 3 Rank YTD Jan Feb Mar Apr C1 May Jun Jul Aug C2 Sep Oct Nov Dec C3 Division Rank 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Zone Rank 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Metric YTD Jan Feb Mar Apr C1 May Jun Jul Aug C2 Sep Oct Nov Dec C3 Secondary Sales Ach. % 95.01 114.76 82.99 88.51 0.0 95.01 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BI Brand Ach. % 100.11 127.58 75.17 97.38 0.0 100.11 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Incremental PMPM 3.39 4.78 4.36 1.02 0.0 3.39 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Frequency Coverage (1) 78.93 0.0 77.23 80.62 0.0 78.93 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Frequency Coverage (2) 81.0 0.0 100.0 62.0 0.0 81.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Frequency Coverage (3) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPD Score 0.55 0.0 0.2 0.9 0.0 0.55 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Call Average 11.41 0.0 10.86 11.96 0.0 11.41 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 YTD Score Trend Metric Weightage Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec YTD Secondary Sales Ach. 30 34.42 29.62 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 BI Brand Ach. 25 30.0 25.36 25.03 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.03 Frequency Coverage (2,3) 25 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 Incremental PMPM (L) 10 3.41 2.91 1.81 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.81 BPD Score 10 0.0 0.23 0.55 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.55 Grand Total 100 67.83 58.12 69.38 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.38 Ranks YTD Composite Score 1 98.0 50 86.46 100 82.57 150 78.99 200 75.99 250 71.82 300 65.81 350 48.89 Action Plan Action Issue Identified Detailed Action Steps Date Note: Incentive Earnings are based on final Enforce secondary sales (with appropriate caps applied as well as manual adjustments) and execution metrics from AbbWorld. Employees with tenure less than 3 months are not eligible for ranking. HPL rank is subject to changes in secondary sales and/or pending AbbWorld reporting. In case of any questions or corrections, please contact 1Point by email 1point@abbott.co.in or call 1800-120-1201 (toll-free)

More Related Content

61 it015707-mar-performance card

  • 1. SALES SCORECARD March 2017 Name Designation Date of Joining Territory Zone Division Rameshvar Lal Srivastava - 731651 TBM 05-JAN-2017 LUCKNOW - IT015707 NORTH3 ACUTE CARE HPL Rank - Division HPL Rank - Zone 0 0 Sales Performance Details - Value Current Month Year - To - Date Brand Class Target Sales Ach % Claims LY Sales Growth PMPM Closing Target Sales Ach % Claims LY Sales Growth PMPM BETONIN AST Build 1.95 0.98 50.4 0.0 0.77 28 0.98 0.8 5.8 3.97 68.4 0.0 1.64 142 1.32 LOBATE GM NEO Build 1.22 2.6 212.2 0.0 0.72 261 2.6 0.74 3.73 6.98 186.9 0.0 1.5 365 2.33 Zimnic Group Build 0.05 0.04 79.0 0.01 0.03 49 0.04 0.15 0.15 0.12 80.6 0.02 0.23 -46 0.04 Deletus Group Invest 0.34 0.12 34.7 0.0 0.03 313 0.12 0.29 1.23 0.52 42.5 0.0 0.19 182 0.17 SURBEX -XT Invest 0.33 0.04 12.4 0.0 0.29 -86 0.04 0.46 1.04 0.36 34.8 0.0 0.48 -25 0.12 AQUAVIRON INJECTION 1ML Maintain 0.17 0.1 60.6 0.0 0.21 -50 0.1 0.18 0.55 0.55 100.3 0.0 0.56 -1 0.18 AVOMINE TABS Maintain 0.12 0.06 53.2 0.0 0.08 -19 0.06 0.23 0.37 0.16 44.0 0.0 0.27 -38 0.05 HAEMACCEL 500ML Maintain 3.64 2.15 58.9 0.01 4.08 -47 2.15 2.15 7.24 5.29 73.0 0.02 5.32 -1 1.76 LYSUPRA Maintain 0.04 0.03 81.3 0.0 0.08 -57 0.03 0.09 0.1 0.06 56.7 0.0 0.14 -59 0.02 Paraxin Group Maintain 0.68 1.01 148.2 0.07 0.76 33 1.01 1.01 2.07 1.62 78.3 0.07 2.06 -21 0.54 BI Total 3.9 3.8 97.3 0.01 1.84 107 3.8 2.47 12.0 12.01 100.1 0.03 4.08 194 4.0 Exit Total 0.0 0.0 0.0 0.0 0.01 -95 0.0 0.03 0.0 0.0 0.0 0.0 0.06 -106 0.0 Milk Total 0.53 1.07 203.0 0.03 0.26 308 1.07 0.54 1.69 2.71 160.5 0.04 1.02 167 0.9 Grand Total 9.63 8.53 88.5 0.12 7.5 14 8.53 7.78 26.4 25.08 95.0 0.17 14.91 68 8.36 Sales Performance Details - Volume Current Month Year - To - Date SKU Class Target Sales Ach % Claims LY Sales Growth PMPM Closing Target Sales Ach % Claims LY Sales Growth PMPM BETONIN AST 170 ML (Without Folic Build 2311 535 23 0 704 -24 535 737 6858 3310 48 2 1351 145 1103 BETONIN AST 400 ML (Without Folic Build 574 666 116 0 415 60 666 360 1711 1992 116 0 979 103 664 LOBATE GM NEO 15GM Build 2918 6967 238 2 2118 229 6967 1996 8902 18725 210 5 4423 323 6241 DELETUS D 100ML SYRUP Invest 322 135 41 0 0 0 135 131 1172 601 51 0 0 0 200 NEW DELETUS BX SYRUP MANGO Invest 52 20 38 0 24 -17 20 138 200 53 26 6 159 -67 17 SURBEX -XT 15S Invest 557 63 11 0 511 -88 63 763 1771 647 36 2 868 -25 215 AQUAVIRON INJ. 1 ML Maintain 229 137 59 3 302 -55 137 237 738 730 98 4 815 -10 243 HAEMACCEL 500ML Maintain 1773 1189 67 4 2170 -45 1189 1208 3541 2955 83 9 2830 4 985 PARAXIN CAPSULES 250 MG 10S Maintain 535 2380 444 0 1598 49 2380 1196 1608 3500 217 3 3733 -6 1166 PARAXIN CAPSULES 500MG 10 S Maintain 379 87 23 0 54 61 87 166 1100 154 14 0 449 -66 51 Brand Targets - Cycle 1 2017 Value Brand Class Jan '17 Feb '17 Mar '17 Apr '17 BETONIN AST Build 1.9 1.95 1.95 2.49 LOBATE GM NEO Build 1.27 1.24 1.22 1.59 Zimnic Group Build 0.05 0.05 0.05 0.06 Deletus Group Invest 0.47 0.43 0.34 0.35 SURBEX -XT Invest 0.36 0.36 0.33 0.39 BI Total 4.06 4.04 3.9 4.89 Grand Total 8.31 8.46 9.63 12.65 Volume SKU Jan '17 Feb '17 Mar '17 Apr '17 AQUAVIRON INJ. 1 ML 280 229 229 229 BETONIN AST 170 ML (Without Folic Acid) 2241 2306 2311 2932 BETONIN AST 400 ML (Without Folic Acid) 560 577 574 742 DELETUS D 100ML SYRUP 441 409 322 333 HAEMACCEL 500ML 788 980 1773 2412 LOBATE GM NEO 15GM 3029 2955 2918 3770 NEW DELETUS BX SYRUP MANGO 100ML 79 69 52 54 PARAXIN CAPSULES 250 MG 10S 554 519 535 760 PARAXIN CAPSULES 500MG 10 S 353 368 379 558 SURBEX -XT 15S 607 607 557 657
  • 2. HPL SCORECARD March 2017 Name Designation Date of Joining Territory Zone Division Rameshvar Lal Srivastava - 731651 TBM 05-JAN-2017 LUCKNOW - IT015707 NORTH3 ACUTE CARE HPL Rank - Division HPL Rank - Zone 0 0 YTD Performance Details Cycle 1 Cycle 2 Cycle 3 Rank YTD Jan Feb Mar Apr C1 May Jun Jul Aug C2 Sep Oct Nov Dec C3 Division Rank 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Zone Rank 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Metric YTD Jan Feb Mar Apr C1 May Jun Jul Aug C2 Sep Oct Nov Dec C3 Secondary Sales Ach. % 95.01 114.76 82.99 88.51 0.0 95.01 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BI Brand Ach. % 100.11 127.58 75.17 97.38 0.0 100.11 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Incremental PMPM 3.39 4.78 4.36 1.02 0.0 3.39 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Frequency Coverage (1) 78.93 0.0 77.23 80.62 0.0 78.93 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Frequency Coverage (2) 81.0 0.0 100.0 62.0 0.0 81.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Frequency Coverage (3) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPD Score 0.55 0.0 0.2 0.9 0.0 0.55 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Call Average 11.41 0.0 10.86 11.96 0.0 11.41 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 YTD Score Trend Metric Weightage Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec YTD Secondary Sales Ach. 30 34.42 29.62 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 BI Brand Ach. 25 30.0 25.36 25.03 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.03 Frequency Coverage (2,3) 25 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 Incremental PMPM (L) 10 3.41 2.91 1.81 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.81 BPD Score 10 0.0 0.23 0.55 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.55 Grand Total 100 67.83 58.12 69.38 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.38 Ranks YTD Composite Score 1 98.0 50 86.46 100 82.57 150 78.99 200 75.99 250 71.82 300 65.81 350 48.89 Action Plan Action Issue Identified Detailed Action Steps Date Note: Incentive Earnings are based on final Enforce secondary sales (with appropriate caps applied as well as manual adjustments) and execution metrics from AbbWorld. Employees with tenure less than 3 months are not eligible for ranking. HPL rank is subject to changes in secondary sales and/or pending AbbWorld reporting. In case of any questions or corrections, please contact 1Point by email 1point@abbott.co.in or call 1800-120-1201 (toll-free)